Giovanna Mulas, PhD - Publications

Affiliations: 
Univ of Cagliari 

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Boi L, Pisanu A, Greig N, Scerba MT, Tweedie D, Mulas G, Fenu S, Carboni E, Spiga S, Carta AR. Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31335998 DOI: 10.1002/mds.27799  0.84
2019 Devoto P, Flore G, Saba P, Scheggi S, Mulas G, Gambarana C, Spiga S, Gessa GL. Noradrenergic terminals are the primary source of α-adrenoceptor mediated dopamine release in the medial prefrontal cortex. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 90: 97-103. PMID 30472147 DOI: 10.1016/j.pnpbp.2018.11.015  0.84
2018 Cannizzaro C, Talani G, Brancato A, Mulas G, Spiga S, Antonietta De Luca M, Sanna A, Anna Maria Marino R, Biggio G, Sanna E, Diana M. Dopamine restores limbic memory loss, dendritic spine structure and NMDAR-dependent LTD in the nucleus accumbens of alcohol-withdrawn rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30446531 DOI: 10.1523/JNEUROSCI.1377-18.2018  0.84
2018 Lecca D, Janda E, Mulas G, Diana A, Martino C, Angius F, Spolitu S, Antonietta Casu M, Simbula G, Boi L, Batetta B, Spiga S, Carta AR. Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease. British Journal of Pharmacology. PMID 29570770 DOI: 10.1111/bph.14214  0.84
2018 Pisanu A, Boi L, Mulas G, Spiga S, Fenu S, Carta AR. Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 29541852 DOI: 10.1007/s00702-018-1874-4  0.84
2016 Mulas G, Espa E, Fenu S, Spiga S, Cossu G, Pillai E, Carboni E, Simbula G, Jadžić D, Angius F, Spolittu S, Batetta B, Lecca D, Giuffrida A, Carta AR. Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease. Experimental Neurology. 286: 83-92. PMID 27697481 DOI: 10.1016/j.expneurol.2016.09.013  0.84
2016 Castelli MP, Spiga S, Perra A, Madeddu C, Mulas G, Ennas MG, Gessa GL. α2A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons. Neuroscience. PMID 27365174 DOI: 10.1016/j.neuroscience.2016.06.037  0.84
2016 Joers V, Tansey MG, Mulas G, Carta AR. Microglial phenotypes in Parkinson's disease and animal models of the disease. Progress in Neurobiology. PMID 27107797 DOI: 10.1016/j.pneurobio.2016.04.006  0.84
2016 Enrico P, Migliore M, Spiga S, Mulas G, Caboni F, Diana M. Morphofunctional alterations in ventral tegmental area dopamine neurons in acute and prolonged opiates withdrawal. A computational perspective. Neuroscience. PMID 26899424 DOI: 10.1016/j.neuroscience.2016.02.006  0.84
2015 Lecca D, Nevin DK, Mulas G, Casu MA, Diana A, Rossi D, Sacchetti G, Carta AR. Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice. Neuroscience. PMID 25907448 DOI: 10.1016/j.neuroscience.2015.04.026  0.84
2014 Spiga S, Mulas G, Piras F, Diana M. The "addicted" spine. Frontiers in Neuroanatomy. 8: 110. PMID 25324733 DOI: 10.3389/fnana.2014.00110  0.84
2014 Pisanu A, Lecca D, Mulas G, Wardas J, Simbula G, Spiga S, Carta AR. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease. Neurobiology of Disease. 71: 280-91. PMID 25134730 DOI: 10.1016/j.nbd.2014.08.011  0.84
2014 Spiga S, Talani G, Mulas G, Licheri V, Fois GR, Muggironi G, Masala N, Cannizzaro C, Biggio G, Sanna E, Diana M. Hampered long-term depression and thin spine loss in the nucleus accumbens of ethanol-dependent rats. Proceedings of the National Academy of Sciences of the United States of America. 111: E3745-54. PMID 25122682 DOI: 10.1073/pnas.1406768111  0.84
2014 Quaranta P, Antonini S, Spiga S, Mazzanti B, Curcio M, Mulas G, Diana M, Marzola P, Mosca F, Longoni B. Co-transplantation of endothelial progenitor cells and pancreatic islets to induce long-lasting normoglycemia in streptozotocin-treated diabetic rats. Plos One. 9: e94783. PMID 24733186 DOI: 10.1371/journal.pone.0094783  0.84
2013 Mulas G, Zonca A, Casu S, Cecchi-Pestellini C. Modeling galactic extinction with dust and "real" polycyclic aromatic hydrocarbons Astrophysical Journal, Supplement Series. 207. DOI: 10.1088/0067-0049/207/1/7  0.01
2011 Spiga S, Acquas E, Puddu MC, Mulas G, Lintas A, Diana M. Simultaneous Golgi-Cox and immunofluorescence using confocal microscopy. Brain Structure & Function. 216: 171-82. PMID 21461741 DOI: 10.1007/s00429-011-0312-2  0.84
2010 Useli-Bacchitta F, Bonnamy A, Mulas G, Malloci G, Toublanc D, Joblin C. Visible photodissociation spectroscopy of PAH cations and derivatives in the PIRENEA experiment Chemical Physics. 371: 16-23. DOI: 10.1016/j.chemphys.2010.03.012  0.01
1994 Todesco S, Del Ross T, Marigliano V, Ariani A, Mulas G. Efficacy and tolerability of etodolac in aged patients affected by degenerative joint disease (osteoarthritis) in its active phase International Journal of Clinical Pharmacology Research. 14: 11-26. PMID 7927957  0.84
1988 Marongiu F, Mameli G, Acca MR, Mamusa AM, Mulas G, Balestrieri A. Low grade DIC in liver cirrhosis: fact or fiction? Thrombosis and Haemostasis. 59: 344-5. PMID 3388306  0.84
1988 Mulas G, Marongiu F, Mameli G, Accalai G, Serpi R, Farci P, Balestrieri A. [Platelet activation in vivo before and after hemodialysis using polyacrylonitrile filters]. Recenti Progressi in Medicina. 79: 195-7. PMID 2972027  0.84
1988 Marongiu F, Mameli G, Acca MR, Mulas G, Medda A, Tronci MB, Mamusa AM, Balestrieri A. Fibrinopeptide A and B beta 15-42 in liver cirrhosis. Haemostasis. 18: 126-8. PMID 2457543  0.84
1987 Marongiu F, Mulas G, Mamusa AM, Mameli G, Marassi PP, Tronci MB, Cambuli AB, Acca MR, Balestrieri AA. Relationship between elevated fibrinopeptide A levels and alpha-2-antiplasmin. Haemostasis. 17: 301-4. PMID 3666588 DOI: 10.1159/000215759  0.84
1987 Marongiu F, Mamusa AM, Mameli G, Mulas G, Cambuli AB, Piga M, Tronci MB, Balestrieri A. Thrombocytopenia and liver cirrhosis evidence for relationship between platelet count, spleen size and hepatic synthetic activity. Thrombosis Research. 45: 275-8. PMID 3660342 DOI: 10.1016/0049-3848(87)90195-2  0.84
1985 Marongiu F, Mamusa AM, Mameli G, Mulas G, Solinas A, Demelia L, Contu L. alpha 2 Antiplasmin and disseminated intravascular coagulation in liver cirrhosis. Thrombosis Research. 37: 287-94. PMID 3975873 DOI: 10.1016/0049-3848(85)90017-9  0.84
1985 Marongui F, Mamusa AM, Mulas G. Effect of a gold salt available for oral use (auranofin) on thrombocyte aggregation in vitro | AZIONE IN VITRO SULL'AGGREGAZIONE PIASTRINICA DA PARTE DI UN NUOVO SALE D'ORO SOMMINISTRABILE PER OS (AURANOFIN) Reumatismo. 37: 275-281.  0.84
1984 Marongiu F, Mamusa AM, Mulas G. Antithrombin and fibrinopeptide A in liver cirrhosis Ircs Medical Science. 12: 199.  0.84
1983 Marongiu F, Mamusa AM, Mulas G. Persistent antithrombin decrease induced by intermittent long-term heparin administration in haemodialysed patients Ircs Medical Science. 11: 1078.  0.84
1982 Marongiu F, Mamusa AM, Solinas A, Demelia L, Mulas G, Perpignano G. [Plasma prekallikrein (Fletcher factor) in hepatic cirrhosis]. Haematologica. 67: 926-30. PMID 6819198  0.84
Show low-probability matches.